Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Clinical Trial
Share your love
Alcon and Ivantis Lose Patent Battle to Sight Sciences.
Sight Sciences announced its success in defeating all four patent invalidity challenges that were filed against it by Alcon and Ivantis in the United States Patent and Trademark Office. Patent Infringement Litigation Over Hydrus® Microstent In September 2021, Sight Sciences…
Brim Biotech’s Clinical Trial for DED Kicks Off
BRIM Biotechnology has initiated the Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED) and enrolled the first patient in the trial. This multicenter, double-blind, randomized, vehicle-controlled trial will enroll over 700 patients with moderate…
Exclusive Interview with Dr. Stanley Windsor at Rayner
● Download RayPRO on App Store and Google Play.● Listen to Peer2Peer on Spotify, Apple Podcasts, Google Podcasts, and Youtube. Question 1: Can you provide an overview of Rayner’s PayPRO and Peer2Peer platforms?Dr. Stanley Windsor, Digital Innovation Manager: Thank you very much for…
Fenofibrate Reduces Diabetic Retinopathy Risk by 27%
In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…
Link Between Antioxidant Supplements and Late-Stage Dry AMD
In a significant development for the treatment of late-stage dry age-related macular degeneration (AMD), researchers at the National Institutes of Health (NIH) have identified that daily antioxidant supplements can potentially slow the progression of the disease, preserving central vision for…
“Cocoa” Increases The Sharpness Of Vision
The acute effect of cocoa and red-berries on visual acuity and cone-mediated dark adaptation in healthy eyes. Researchers at the Universidad Complutense de Madrid have found that consuming pure cocoa can help improve vision in daylight. This recent research sheds light…
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…
FDA Notifies Ocugen to Begin Expanded Access Program RP
The FDA has authorized Ocugen, Inc. to launch an expanded access program (EAP) for patients aged 18 and older with retinitis pigmentosa (RP), providing early access to its promising gene therapy candidate, OCU400. The treatment has shown encouraging results in…
Bausch + Lomb’s TENEO Laser Achieves Strong LASIK Outcomes
Bausch + Lomb recently published the results of a pivotal clinical trial for its TENEO™ Excimer Laser in the Journal of Refractive Surgery. This study, which played a crucial role in securing U.S. FDA approval for the device in January…